NDLI: National trends in prescription drug expenditures and projections for 2015.

Please wait, while we are loading the content...

National trends in prescription drug expenditures and projections for 2015.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Schumock, Glen T. Li, Edward C. Suda, Katie J. Wiest, Michelle D. Stubbings, Joann Matusiak, Linda M. Hunkler, Robert J. Vermeulen, Lee C.
Spatial Coverage	United States
Description	Author Affiliation: Schumock GT ( Glen T. Schumock, Pharm.D., M.B.A., Ph.D., FCCP, is Professor and Head, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago. Edward C. Li, Pharm.D., M.P.H., BCOP, is Associate Professor, Department of Pharmacy Practice, College of Phar); Li EC ( Glen T. Schumock, Pharm.D., M.B.A., Ph.D., FCCP, is Professor and Head, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago. Edward C. Li, Pharm.D., M.P.H., BCOP, is Associate Professor, Department of Pharmacy Practice, College of Phar); Suda KJ ( Glen T. Schumock, Pharm.D., M.B.A., Ph.D., FCCP, is Professor and Head, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago. Edward C. Li, Pharm.D., M.P.H., BCOP, is Associate Professor, Department of Pharmacy Practice, College of Phar); Wiest MD ( Glen T. Schumock, Pharm.D., M.B.A., Ph.D., FCCP, is Professor and Head, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago. Edward C. Li, Pharm.D., M.P.H., BCOP, is Associate Professor, Department of Pharmacy Practice, College of Phar); Stubbings J ( Glen T. Schumock, Pharm.D., M.B.A., Ph.D., FCCP, is Professor and Head, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago. Edward C. Li, Pharm.D., M.P.H., BCOP, is Associate Professor, Department of Pharmacy Practice, College of Phar); Matusiak LM ( Glen T. Schumock, Pharm.D., M.B.A., Ph.D., FCCP, is Professor and Head, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago. Edward C. Li, Pharm.D., M.P.H., BCOP, is Associate Professor, Department of Pharmacy Practice, College of Phar); Hunkler RJ ( Glen T. Schumock, Pharm.D., M.B.A., Ph.D., FCCP, is Professor and Head, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago. Edward C. Li, Pharm.D., M.P.H., BCOP, is Associate Professor, Department of Pharmacy Practice, College of Phar); Vermeulen LC ( Glen T. Schumock, Pharm.D., M.B.A., Ph.D., FCCP, is Professor and Head, Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago. Edward C. Li, Pharm.D., M.P.H., BCOP, is Associate Professor, Department of Pharmacy Practice, College of Phar)
Abstract	PURPOSE: An analysis of trends in U.S. pharmaceutical spending is presented, including projections for drug expenditures in nonfederal hospital and clinic settings in 2015. METHODS: Prescription drug expenditure data through September 2014 were obtained from the IMS Health National Sales Perspectives database and were analyzed descriptively. Other factors that may influence prescription spending in hospitals and clinics in 2015, including new drug approvals and patent expirations, were analyzed. Expenditure projections were based on a combination of quantitative and qualitative analyses and expert opinion. RESULTS: Total prescription sales for the 12 months ending September 30, 2014, were \$360.7 billion, 12.2% higher than during the previous 12 months. With \$6.6 billion in expenditures in the first 9 months of 2014, sofosbuvir topped the overall list of drugs based on sales, followed by aripiprazole and insulin glargine. Pharmaceutical spending by clinics and nonfederal hospitals rose by 13.3% and 4.0%, respectively. For the first 9 months of 2014, the top drugs based on expenditures were infliximab, pegfilgrastim, and epoetin alfa in clinics and infliximab, rituximab, and pegfilgrastim in hospitals. Specialty drugs continued to constitute an increasing portion of drug expenditures and will contribute to higher expenditures in 2015. CONCLUSION: Growth in U.S. prescription drug expenditures is expected to continue to increase in 2015. The projected increases in total drug expenditures are 7-9% across all settings, 12-14% in clinics, and 5-7% in hospitals. Health-system pharmacy leaders should carefully examine their own local drug utilization patterns to determine their own organization's anticipated spending in 2015.
File Format	HTM / HTML
ISSN	10792082
Issue Number	9
Volume Number	72
e-ISSN	15352900
Journal	American Journal of Health-System Pharmacy
Language	English
Publisher	American Society of Health-System Pharmacists
Publisher Date	2015-05-01
Publisher Place	United States
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Drug Costs Economics Patents As Topic United States Humans Discipline Pharmacy Drug Approval Health Expenditures Journal Article Hospitals Prescription Drugs Statistics & Numerical Data Trends
Content Type	Text
Resource Type	Article
Subject	Pharmacology Pharmacy Health Policy

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

National trends in prescription drug expenditures and projections for 2014.

Projecting future drug expenditures--2012.

National trends in prescription drug expenditures and projections for 2021.

Recent trends in brand-name and generic drug competition.

Projecting future drug expenditures--2010.

Projecting future drug expenditures: 2011.

National trends in prescription drug expenditures and projections for 2022.

Children's hospitals seek drug-cost savings through 340B participation.

Global reach of online direct-to-consumer drug advertising.

National trends in prescription drug expenditures and projections for 2015.

Similar Documents

National trends in prescription drug expenditures and projections for 2014.

Projecting future drug expenditures--2012.

National trends in prescription drug expenditures and projections for 2021.

Recent trends in brand-name and generic drug competition.

Projecting future drug expenditures--2010.

Projecting future drug expenditures: 2011.

National trends in prescription drug expenditures and projections for 2022.

Children's hospitals seek drug-cost savings through 340B participation.

Global reach of online direct-to-consumer drug advertising.

National trends in prescription drug expenditures and projections for 2015.